Skip to content
10-Q

Quarterly Report

Galera Therapeutics, Inc. GRTX

0001193125-25-278816

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 75.46M sh
Shares Diluted Q3 2025 · Sep 30, 2025 98.5M sh
Shares Diluted Q3 2025 · Sep 30, 2025 98.5M sh
Shares Diluted Q3 2025 · Sep 30, 2024 54.39M sh
Shares Diluted Q3 2025 · Sep 30, 2024 54.39M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$4.45M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$9.81M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $4.47M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $8.29M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$149.22M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$147.95M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$147.23M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$148.04M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$143.06M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$138.03M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$134.69M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$131.19M
Current Liabilities Q3 2025 · Sep 30, 2025 $598K
Current Liabilities Q3 2025 · Dec 31, 2024 $1.67M
Total Liabilities Q3 2025 · Sep 30, 2025 $151.65M
Total Liabilities Q3 2025 · Dec 31, 2024 $153.77M
Current Assets Q3 2025 · Sep 30, 2025 $4.9M
Current Assets Q3 2025 · Dec 31, 2024 $10M
Total Assets Q3 2025 · Sep 30, 2025 $5M
Total Assets Q3 2025 · Dec 31, 2024 $10.1M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.01
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.02
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.10
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.26
Eps Basic Q3 2025 · Sep 30, 2025 −$0.01
Eps Basic Q3 2025 · Sep 30, 2025 −$0.02
Eps Basic Q3 2025 · Sep 30, 2024 −$0.10
Eps Basic Q3 2025 · Sep 30, 2024 −$0.26
Sga Expense Q3 2025 · Sep 30, 2025 $1.31M
Sga Expense Q3 2025 · Sep 30, 2025 $4.23M
Sga Expense Q3 2025 · Sep 30, 2024 $3.44M
Sga Expense Q3 2025 · Sep 30, 2024 $9.31M
Rd Expense Q3 2025 · Sep 30, 2025 $130K
Rd Expense Q3 2025 · Sep 30, 2025 $307K
Rd Expense Q3 2025 · Sep 30, 2024 $305K
Rd Expense Q3 2025 · Sep 30, 2024 $3.22M
Net Income Q3 2025 · Sep 30, 2025 −$1.39M
Net Income Q3 2025 · Sep 30, 2025 −$4.06M
Net Income Q3 2025 · Jun 30, 2025 −$1.08M
Net Income Q3 2025 · Mar 31, 2025 −$1.59M
Net Income Q3 2025 · Sep 30, 2024 −$5.58M
Net Income Q3 2025 · Sep 30, 2024 −$14.03M
Net Income Q3 2025 · Jun 30, 2024 −$4.06M
Net Income Q3 2025 · Mar 31, 2024 −$4.38M
Operating Income Q3 2025 · Sep 30, 2025 −$1.44M
Operating Income Q3 2025 · Sep 30, 2025 −$4.53M
Operating Income Q3 2025 · Sep 30, 2024 −$5.91M
Operating Income Q3 2025 · Sep 30, 2024 −$14.69M
Stock Issued Q3 2025 · Dec 31, 2024 21.07M sh
Stock Issued Q3 2025 · Dec 30, 2024 21.07M sh